Tag: Swiss Pharma

Swissmedic Creates Signal Notification Form in Change to 2020 Requirements

The Swiss Agency for Therapeutic Products (Swissmedic) has created a signal notification form as part of a change in how it will collect safety data. Starting in January, Swissmedic will ask marketing...

Swissmedic Adapting Requirements for Combination Products to MDR

The Swiss Agency for Therapeutic Products (Swissmedic) is working on adapting the requirements for combination products to the new EU Medical Devices Regulation (MDR). A notification was published...

Belarus to Cooperate Swiss University Center of Legal Medicine

The University Center of Legal Medicine, Lausanne–Geneva and the scientific and practical center of the State Forensic Examination Committee of Belarus have signed an agreement on cooperation, BelTA l...

Swiss Drug Law Review

On 1 January 2019, the revised Swiss Therapeutic Products Act (HMG 2) and the majority of the revised implementing ordinances (Therapeutic Products Ordinance Package IV) entered into force - with some...

WuXi STA and BioLingus in Exclusive Technology Collaboration

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing collaboration for subling...

Swiss–Georgian Partnership

Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Softwa...

Swissmedic Started to Enter GMP Compliance Information into EudraGMDP

The Swiss Agency for Therapeutic Products (Swissmedic) has started in 2019 to enter information on Good manufacturing practice (GMP) compliance as well as on manufacturing authorisations related to Sw...

Swiss and China Companies Entered into Agreement

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agre...

Philogen Keeps Extending Relations

Philogen S.p.A., a privately-owned biotechnology company, through its wholly-owned Swiss subsidiary, Philochem AG, has announced two discovery collaborations. The first is with J&J’s biopharma ...

Swissmedic GMP Compliance Document for Foreign Manufactures

The Swiss authority Swissmedic has published a new auxiliary document. This document is intended to clarify which documents should be submitted as part of an authorisation application with type IA/IAI...

Sophia Genetics Raises $77mln to Expand its Technology

Healthtech company Sophia Genetics has announced it has raised $77 million to help accelerate its technologies into data-driven medicine. The latest funding round, led by Generation Investment Mana...